YTHDF1 was demonstrated to promote proliferation of cancer cells in nonsmall cell lung cancer (NSCLC), whereas paradoxically, better prognosis and chemotherapy sensitivity were correlated with high YTHDF1 expression and implied the complicated and multiple mechanisms lurking beneath the phenomena observed above [38]. The gene discussed is YTHDF1; the disease is non-small cell lung carcinoma.